01オクタクロロスチレン.PDF

Size: px
Start display at page:

Download "01オクタクロロスチレン.PDF"

Transcription

1 [Octachlorostyrene, CAS No ] ( ) OCS C 8 C l Pa (25 ) Log Pow = 6.29 ( ) 2) mg/l (25 ) HSDB, 2001; 2 PHYSPROP,

2 1. 1) (OCS) 9 OCS OCS 75 4 Selden et al., OCS (Selden et al., 1998) Selden et al., OCS ppb 0.24 ppb 1.24 ppb OCS Lunde et al., PCBs DDT OCS 1 ng/g (Mes et al., 1990) 25 OCS (< 0.06 ng/g ) 0.5 ng/g Mes, OCS (< ng/g ) Mes et al., OCS 497 7% 0.05 ng/g 2.16ng/g Newsome et al., 1995 OCS 136 OCS 1.5 ng/ml < ng/ml Lommel et al., 1985, ) (1) in vitro -1 OCS 10-4 M 2

3 CERI, M ERE CERI, 2001; Yamasaki et al., 2001 (2) -2 OECD SD 20 3 OCS mg/kg/day Yamasaki et al., 2001 OCS SD OCS 0 1,300 1,690 2,190 2,850 3,710 mg/kg 1,300 mg/kg Chu et al., 1982a SD OCS 3 (1) ppm ( : mg/kg/day. : mg/kg/day ) 28 Chu et al., 1982a (2) ppm ( : mg/kg/day. : mg/kg/day ) 90 (Chu et al., 1984) (3) ppm ( : mg/kg/day. : mg/kg/day ) 12 (Chu et al., 1986) ppm 0.5 ppm 5 ppm 3) (1) -1 SD 0 1,300 1,690 2,190 2,850 3,710 mg/kg 1,300 mg/kg 2,850 mg/kg 3,710 mg/kg (Chu et al., 1982a) 3

4 -1 LD 50 > 3,710 mg/kg LC 50 LD 50 LD 50 (2) -3 SD OCS 2)-(2) Chu ppm ( : mg/kg/day. : mg/kg/day ) 28 (Chu et al., 1982a) ppm ( : mg/kg/day. : mg/kg/day ) 90 (Chu et al., 1984) ppm ( : mg/kg/day. : mg/kg/day ) 12 (Chu et al., 1986) OCS ppm 5.0 ppm ppm 5 ppm ppm 5 ppm 50 ppm 5 ppm 50 ppm ppm 500 ppm 0.05 ppm 50 ppm / (M/E) 4 (1) -2 OCS (Tarkpea et al., 1985) 4

5 in vitro -2 * TA98 TA100 S9(-/+) 2-4,000 µg/plate * Tarkpea et al., 1985 (2) -3 SD 12 OCS (Chu et al., 1986) -3 EPA IRIS, 2002 EU ECB, 2000 NTP NTP, 2000 IARC IARC, 2001 ACGIH ACGIH 2001, SD ( g) [8-14 C] ( 14 C-OCS) 20 mg/kg OCS 14 C-OCS 40 mg/kg 1 8% 90% 10% Chu et al., 1982b) OCS C57BL/6J (B6) OCS mg/kg 5 P450 b5 NADPH-P450 -N- 4- -O- -4-5

6 Holme and Dybing, 1982a Wistar OCS mg/kg 5 P450 NADPH- P450 -N O- -4- [a] OCS 250 mg/kg 1 8 Holme and Dybing, 1982b Wistar OCS 200 mg/kg P450 -S- UDP- Holme and Dybing, in vitro OCS 6

7 ACGIH (2001) American Conference of Governmental Industrial Hygienists. Documentation of the threshold limit values and biological exposure indices. Seventh Edition, Cincinnati, Ohio, 200. Chu, I., Secours, V.E., Villeneuve, D.C., and Valli, V.E., (1982a) Acute and subacute toxicity of octachlorostyrene in the rat. J. Toxicol. Environ. Health, 10, Chu, I., Villeneuve, D.C., Secours, V., Benoit, F.M., and Viau, A. (1982b) The tissue distribution, metabolism, and excretion of octachlorostyrene in the rat. Drug Metab. Dispos., 10, Chu, I., Villeneuve, D.C., Secours, V.E., Yagminas, A., Reed, B., and Valli, V.E. (1984) Octachlorostyrene: a 90-day toxicity study in the rat. Fund. Appl. Toxicol., 4, Chu, I,. Villeneuve, D.C., Secours, V.E., Valli, V.E., Leeson, S., and Shen, S.Y. (1986) Long-term toxicity of octachlorostyrene in the rat. Fund. Appl. Toxicol., 6, ECB (2000) Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labeling of dangerous substances ANNEX I ( Holme, J.A. and Dybing, E. (1982a) Induction of liver microsomal cytochrome P 450 and associated monooxygenases by octachlorostyrene in inbred strains of mice. Lack of correlation with the murine Ah locus. Biochem. Pharmacol., 31, Holme, J.A. and Dybing, E. (1982b) Induction of liver microsomal cytochrome P-450 and associated monooxygenases by octachlorostyrene in the rat. Acta Pharmacol. Toxicol., 50, Holme, J.A. and Dybing, E.(1983) Increased cytochrome P 450 independent drug metabolism and mutagen activation in rat liver by octachlorostyrene. Acta Pharmacol. Toxicol., 53, HSDB (2001) Hazardous Substances Data Bank, National Library of Medicine, ( IARC (2001) IARC Monograph on the Evaluation of Carcinogenic Risks to Humans. IRIS (2002) Integrated Risk Information System, National Library of Medicine, ( Lommel, A., Kruse, H., and Wassermann, O. (1985) Organochlorines and mercury in blood of a fish-eating population at the River Elbe in Schleswig-Holstein, FRG. Arch. Toxicol., Suppl. 8, Lommel, A., Kruse, H., Muller, E., and Wassermann, O. (1992) Organochlorine pesticides, octachlorostyrene, and mercury in the blood of Elb River residents, Germany. Arch. 7

8 Environ. Contam. Toxicol., 22, Lunde, G. and Bjorseth, A. (1977) Human blood samples as indicators of occupational exposure to persistent chlorinated hydrocarbons. Sci. Total Environ., 8, Mes, J., Marchand, L., and Davies, D.J. (1990) Organochlorine residues in adipose tissue of Canadians. Bull. Environ. Contam. Toxicol., 45, Mes, J. (1992) Organochlorine residues in human blood and biopsy fat and their relationship. Bull. Environ. Contam. Toxicol., 48, Mes, J., Davies, D.J., Doucet, J., Weber, D., and McMullen, E. (1993) Levels of chlorinated hydrocarbon residues in Canadian human breast milk and their relationship to some characteristics of the donors. Food. Addit. Contam., 10, Newsome, W.H., Davies, D., and Doucet, J. (1995) PCB and organochlorine pesticides in Canadian human milk Chemosphere, 30, NTP (2000) U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program, 9th Report on Carcinogens. PHYSPROP (2000) Syracuse Research Corporation Physical Properties Database, ( Selden, A.I., Nygren, Y., Westberg, H.B., and Bodin, L.S. (1997) Hexachlorobenzene and octachlorostyrene in plasma of aluminium foundry workers using hexachloroethane for degassing. Occup. Environ. Med., 54, Selden, A.I., Floderus, Y., Bodin, L.S., Westberg, H.B., and Thunell, S. (1998) Porphyrins in aluminium foundry workers exposed to hexachlorobenzene and octachlorostyrene. Organohalogen Compounds, 38, Selden, A.I., Floderus, Y., Bodin, L.S., Westberg, H.B., and Thunell, S. (1999) Porphyrin status in aluminum foundry workers exposed to hexachlorobenzene and octachlorostyrene. Arch. Environ. Health, 54, Tarkpea, M., Hagen, I., Carlberg, G.E., Kolsaker, P., and Storflor, H. (1985) Mutgenicity, acute toxicity, and bioaccumulation potential of six chlorinated styrenes. Bull. Environ. Contam. Toxicol., 35, Yamasaki, K., Takeyoshi, M., Yakabe, Y., Sawaki, M., Imatanaka, M., and Takatsuki, M. (2001) Comparison of reporter gene assay and immature rat uterotrophic assay of twenty-three chemicals. Toxicology, 170, CERI ( ) , (2001),, 43,

9 -1 in vitro ER ER IC50 >10-4 M ER CERI, 2001 ( ER (E M) ) ER M ER CERI, 2001 ER HeLa (E2 PC50: <10 11 M) M ER M ER Yamasaki et ER al., 2001 HeLa M (E2: PC50: <10 9 M) ER: ; E2: 17 - ; PC50: E2 50 ; IC50: E2 50 9

10 Yamasaki et al., (SD ) ( 3 mg/kg/day 2001 ) 1 0 1,300 1,690 1,300 mg/kg Chu et al., 1982a (SD ( 2,190 2, g ) ) 3,710 mg/kg ppm Chu et al., 1982a (SD, g;, g) ( 500 ppm ) ( : mg/kg/day : mg/kg/day ) ppm Chu et al., 1984 (SD / ) ( ppm ) ( : mg/kg/day : ppm mg/kg/day ) 0.05 ppm 500 ppm ppm Chu et al., 1986 (SD, g;, g) ( ppm ) ( : mg/kg/day : ppm ppm mg/kg/day ) 5 ppm 10

11 -3 ; ppm ( 50 ppm Chu et al., (SD ( : ppm) 1982a, g; 35 mg/kg/day, g) : mg/kg/day ) ( 5 ppm 0.5 ppm) ( 5 ppm 50 ppm) ( 50 ppm) ( 5 ppm 50 ppm) ( 500 ppm) ( 500 ppm) ( 500 ppm) ; Chu et al., (SD / ) 500 ppm ( : mg/kg/day : mg/kg/day ) ( 5 ppm) 1984 ( 50 ppm) (500 ppm) (500 ppm) ; ( 0.05 ppm) M/E ( 0.5 ppm) ( 5 ppm) ; M/E ( 50 ppm) P/M ( ) ( 50 ppm) ( 0.05 ppm) ( 500 ppm) ( 5 ppm 50 ppm) ( 500 ppm) ( 500 ppm) 11

12 ( Chu et al., (SD, g; 50 ppm ( : ppm) 1986 ( 50 ppm ), g) mg/kg/day ( ppm) : mg/kg/day ) ( 0.005ppm) ( ppm) ( 5 ppm) ( ppm) ( 5 ppm) ( 5 ppm 50 ppm) 12

橡99-24_00 アリルアルコール.PDF

橡99-24_00 アリルアルコール.PDF 1 9924 2260 CAS 107186 H 2 C CH CH 2 OH 2- -1- C 3 H 6 O 58.08 1 99 1. 2, 3 3, 4, 5-129 96-97 2 21c.c. 24o.c. 2 6, 7 378 6, 7 2.5-18 d 20 4 0.8540 2, 5 2.00 = 1 2.7 kpa 20 mmhg204.3 kpa 32 mmhg30 4 log

More information

CAS NC(CH 2 ) 4 CN 1,4- C 6 H 8 N c.c d = Pa

CAS NC(CH 2 ) 4 CN 1,4- C 6 H 8 N c.c d = Pa 1 200117 21512 CAS 111693 110 NC(CH 2 ) 4 CN 1,4- C 6 H 8 N 2 108.14 1 99 2-1. 2 1 295 159 c.c. 550 3 1.7-4.9 20 d 0.965 4 3.73 = 1 0.3 Pa 0.002 mmhg20 2 log Pow-0.32 m/z 41, 1.0 68 0.54 54 0.43 4 Koc9-16

More information

3, ,104 t mg/l 30 mg/l BOD mg 14 C 8, /kg 11 8, 1 11 OH = cm 3 / sec 11 OH /cm ppm

3, ,104 t mg/l 30 mg/l BOD mg 14 C 8, /kg 11 8, 1 11 OH = cm 3 / sec 11 OH /cm ppm 3, 3-1 200019 4800 CAS 91941 1138 3, 3-4, 4 - -3, 3 - H 2 N Cl Cl NH 2 C 12 H 10 C l2 N 2 253.13 1 95 1. 2 3, 4 132-133 402 5 >200 5 700kg/m 3 5 8.73 = 1 5.610-8 kpa 4.210-7 mmhg20 4 6 log Pow3.51 3.57

More information

CAS H 3 C C CH 2 C 9 H tert d = hpa

CAS H 3 C C CH 2 C 9 H tert d = hpa 1 200140 35 CAS 98839 1335-2- H 3 C C CH 2 C 9 H 10 118.18 1 99 4-tert- 1. 2-23.2 2 163164 2 54 574 3 0.96.6 20 d 4 0.9082 2 4.07 = 1 2.5 hpa 1.9 mmhg20 2 4 log Pow3.48 3.44 m/z 118, 1.0 103 0.58 91 0.21

More information

橡フタル酸ブチルベンジル.PDF

橡フタル酸ブチルベンジル.PDF 1 97 7 3 1312 CAS 85 68 7 O BBP 1, 2- C 19 H 20 O 4 312.4 C C O O O (CH 2 ) 3 1 99.9 % 1. 2-35 3 2, 3 370 3, 4 199 d 25 4 1.117 2 10.8 = 1 5 1.15 10-3 Pa 8.6 10-6 mmhg 20 5 253 Pa 1.9 mmhg 200 5 log Pow

More information

橡96-07.PDF

橡96-07.PDF 1 967 2482 CAS 50000 CH 2 O 30.03 2952% 12.5 % 1. 2) -92 2) -19.5 2) 5085 3) 424 3) 7.073.0% 4) 20 d 4 0.815 5) 1.03 ( = 1) 5) 1.33 kpa (10 mmhg) (-88.0) 2) log Pow0.35 ( ) 6) 0.35 ( ) 7) 1) m/z 29 ( 1.0

More information

t 492 t mg/l 30 mg/l BOD 95 OH = cm 3 / sec 25 8 OH /cm 3 12 = ph ph

t 492 t mg/l 30 mg/l BOD 95 OH = cm 3 / sec 25 8 OH /cm 3 12 = ph ph 2-1 200169 2740 CAS 110-49-6 1103 2- O H 3 C C O CH 2 CH 2 O CH 3 C 5 H 10 O 3 118.13 200168 2-1 99 2-1. 2 2, 3-65 2, 3 144145 45 o.c. 3 392 3 1.512.3 d19 1.009 2 4.07 = 1 30 Pa 0.23 mmhg20 2 4 log Pow0.10

More information

02スチレンダイマー、トリマー.PDF

02スチレンダイマー、トリマー.PDF [Styrene dimer, CAS No. 25247-68-1; Styrene trimer, 28213-80-1] -1,2 C 16 H 16 C 24 H 24 208.2 312.3 4 7 2-1,2 CH 2 CH 2 2,4- -1-2,4,6- -1-1,2-1,3,5-760 21,430 g/g 9,590 g/g 2 3 HSDB, 2001 ; 2, 1998; 3

More information

,977 t 157,977 t mg l mg l BOD 9398 % OH = cm 3 / sec 11 = cm 3 / sec OH = /

,977 t 157,977 t mg l mg l BOD 9398 % OH = cm 3 / sec 11 = cm 3 / sec OH = / 1 9625 2219 CAS 75569 1, 2-1, 2- H 2 C CH CH 3 C 3 H 6 O 58.08 1 99 % 1. 2 2, 3-112.13 2, 3 34.23-37 449 2.8-37 % 2 d 0 4 0.859 4 d 20 0.8304 2 2, 4 2.00 = 1 53.33 kpa 400 mmhg18 59.33 kpa 445 mmhg20 5

More information

CAS O C O * DOP* DEHP 2- C O O * n- C 24 H 38 O CH 2 CH 2 CH 2 CH 3 CH (CH 2 ) % 2- A BHT , 4

CAS O C O * DOP* DEHP 2- C O O * n- C 24 H 38 O CH 2 CH 2 CH 2 CH 3 CH (CH 2 ) % 2- A BHT , 4 2-1 9628 31307 CAS 117817 2- O C O * DOP* DEHP 2- C O O * n- C 24 H 38 O 4 390.56 CH 2 CH 2 CH 2 CH 3 CH (CH 2 ) 3 1 99 % 2- ABHT 1. 2-55 3 3, 4 386 171 350 6 0.1 % d 20 4 0.9861 4 13.48 0.30410-4 Pa 2.2810-7

More information

,309 t 22,069 t 7,240 t µg/l µg/l < ,431-70, , , mg/l m

,309 t 22,069 t 7,240 t µg/l µg/l < ,431-70, , , mg/l m 1 20019 1527 CAS 1317368 1230 PbO 223.20 1 99 1. 2 888 2 9.53 0.017 g/l 20 3 3 2 2. 10 29,309 t 22,069 t 7,240 t 4 1 3. 1 2 3.5 6 1 µg/l 9.1-24 2 µg/l < 43 6 27,431-70,000 4.5-1,300 13.4-17 31.7 0.48-3,459

More information

,161 t 9,753 t 2,408 t LC 50 mg/ L EC 50 mg/l * 5 : Selenastrum 6772-h, Sb 2 O 3, : capricornutum 6 3 Selenastrum h, Sb

,161 t 9,753 t 2,408 t LC 50 mg/ L EC 50 mg/l * 5 : Selenastrum 6772-h, Sb 2 O 3, : capricornutum 6 3 Selenastrum h, Sb 1 20017 1543 CAS 1309644 125 Sb 2 O 3 291.52 1 99 1. 2 655 1,425 2 2 2 3 5.2 5.67 2 2 2. 10 12,161 t 9,753 t 2,408 t 4 3. 1 2 3 4. LC 50 mg/ L EC 50 mg/l * 5 : Selenastrum 6772-h, Sb 2 O 3, : capricornutum

More information

98-02.PDF

98-02.PDF 1 982 2207 CAS 67630 2- H 3 C H 3 C CH OH C 3 H 8 O 60.10 1 99.9 % n- 1. 2-88.5 3 82.5 3 11.7c.c. 455 4 212 d 20 4 0.78505 3 2.1 = 1 4 4.4 kpa 33 mmhg20 4 log Pow0.05 0.07 5 m/z45, 1.0 43 0.19 27 0.17

More information

橡アジポニトリル.PDF

橡アジポニトリル.PDF 1 200117 21512( ) CAS 111693 110( ) 1,4- NC(CH 2 ) 4 CN C 6 H 8 N 2 108.14 1) 99 2-1. 2) 1 2) 295 2) 159(c.c.) 3) 550 3) 1.7-4.9 vol % ( ) 3) d 20 0.965 2) 3.73 ( = 1) 4 0.3 Pa (0.002 mmhg) (20) 2) log

More information

橡三酸化二アンチモン.PDF

橡三酸化二アンチモン.PDF 1 2001 7 1 543( ) CAS 1309 64 4 1 25 ( ) Sb 2 O 3 291.52 1) 99 1. 2) 655 3) 1,425 3) ( ) 2) ( ) 2) ( ) 2) 5.2 ( ) 5.67 ( ) 3) 2) 2. 10 12,161 t ( 9,753 t 2,408 t) 4 2 1) 3. 1) 2) 3) 4. Selenastrum capricornutum

More information

http://www.who.int/ipcs/publications/ehc/en/index.html EHC 1 2 3 4 / EHC http://www.nihs.go.jp/dcbi/publist/ehchsg/ 1-8) WHO/IPCS CICAD (Concise Inter

http://www.who.int/ipcs/publications/ehc/en/index.html EHC 1 2 3 4 / EHC http://www.nihs.go.jp/dcbi/publist/ehchsg/ 1-8) WHO/IPCS CICAD (Concise Inter 3 [ ] Priority IARC JMPR 2004 10 Priority 1 Priority 1 Priority 2 Priority 3 Priority 1 1-1) CERI) http://www.cerij.or.jp/ceri_jp/koukai/sheet/sheet_indx4.htm http://www.safe.nite.go.jp/data/sougou/pk_list.html?table_name=hyoka&rank=sh

More information

橡96-01.PDF

橡96-01.PDF 1 961 31 CAS 71432 C 6 H 6 78.11 1) 99 % 1. 5.5 2) 80.1 2) -11 3) 293563 3) 1.48.0% 3) d 20 0.8786 4) 2.77 ( = 1) 4) 4 13.33 kpa (100 mmhg) (26.9) 2) log Pow2.13 ( ) 5) 2.14 ( ) 6) m/z78 ( 1.0 )77 ( 0.20

More information

化学物質の環境リスク初期評価(平成9~12年度)結果[39物質]

化学物質の環境リスク初期評価(平成9~12年度)結果[39物質] (1) CAS 302-01-2 N 2 H 4 32.0 CAS 7803-57-8 2 1) 2.0 2,3) 113.5 2,4) 1.011 (15 ) 2,3) 1.0036 (25 ) 2,4) 2.1 kpa (16 mmhg) (20 ) 3) 1ppm=1.31 mg/m 3 at 25, n- / -1.37 ( ) 3) 5) K b1 8.510-7 K b2 8.910-16

More information

化学物質の環境リスク初期評価(平成9~12年度)結果[39物質]

化学物質の環境リスク初期評価(平成9~12年度)結果[39物質] 1,3-1,3- (1) 1,3-1,3- - CAS 542-75-6 C 3 H 4 Cl 2 110.97 2 1) -84 2) 108 2,3) 112 (trans-) 4) 104 (cis-) 4) 1.225 (20 ) 2) 5.2 kpa (39 mmhg) (25 ) 2) 4.5 kpa (34 mmhg) (25 ) 4) 5.7 kpa (43 mmhg) (25 )

More information

040202PC用.doc

040202PC用.doc 15 48 15 8 25 15 1321 15 8 25 0825002 15 8 25 6 8 15 2 18 15 6 27 2 15 3 13 28 35 (1) 51 198 7 (2) 3 6 1 100g (1) 1 (1) 1 2 1 astaxanthin;3,3 -dihydroxy-, -carotene-4,4 -dione (2) 1 2 C40H52O4 596.86 97.0

More information

化学物質の環境リスク初期評価(平成9~12年度)結果[39物質]

化学物質の環境リスク初期評価(平成9~12年度)結果[39物質] (1) 1,2- DMP CAS 131-11-3 C 10 H 10 O 4 194.2 2 1) 5.5 2,3) 283.7 2,3) 1.192 (20 ) 4) 133 Pa (1 mmhg) (20 ) 5) 1ppm=7.94 mg/m 3 at 25, n- / 1.56 ( ) 6) 4) ( )3.2 (30 ph 7)11.6 (30 ph 9)25 (18 ph 9) 5)

More information

初期リスク評価報告書作成指針(案)

初期リスク評価報告書作成指針(案) BCF: Bioconcentration Factor EC 50 : Median Effect Concentration 1 50 EEC: Estimated Environmental Concentration EHI: Estimated Human Intake EUSES: Europian Union System for the Evaluation of Substances

More information

DCHP

DCHP 2. 2 1. 1) 2) 2 Crj:CD(SD)IGS SPF 0 240 1200 6000 ppm 2 F0 10 F0 10 F1 21 F1 3 10 F1 3 10 F2 21 0 240 1200 6000 ppm 1 F0 0 15.88 79.57 401.8 mg/kg/day F0 0 20.80 104.19 510.7 mg/kg/day F1 0 17.84 89.89

More information

資料1(目消し版).ppt

資料1(目消し版).ppt 1 Dr. Grandjean 2 15 45 3 4 CH 3 Hg + Hg 0 fi Hg ++ fich 3 + MeHg MeHg 5 Methylmercury-2 6 :, A. Yasutake 7 - A. Yasutake 8 :,. A. Yasutake 9 A. Yasutake 10 (%) : : : : : MeHg 0.05 250 : 2 : 1 : 0.1 :

More information

0774 CAS No. 111-15-9 2014 3 25 0774 1 3 1 3 11 3 12 3 13 3 2 3 3 4 31 4 32 4 4 4 5 1 5 11 5 12 5 13 5 14 5 15 5 16 6 17 6 2 7 21 7 22 7 23 7 1 7 2 8 3 8 3 8 31 8 32 9 33 9 34 9 35 9 36 9 37 10 1 10

More information

untitled

untitled ... 4...5...6...7...10...11... 12...12...12...13...14...15...15...16...16...17...17...18...18...19...19...19 Hill...20...20...21...21...22...23...24...25... 34...34...35...38-2 - ...41...49...51...51...51...52...53...56...56...57...60...60-3

More information

0 0 0 0............ PNEC.............................. PNECsed.................. 0 0 0 0 PNEC logpow. * Oncorhynchus mykisslc0. mg/l UFs0,000 0.000 mg/l0. µg/lpnec PNECwater PNECwater * Sangster, J. ()

More information

Microsoft Word - 「黄砂とその健康影響について」小冊子180323版

Microsoft Word - 「黄砂とその健康影響について」小冊子180323版 ...1...1...1...2...4...4...4...6...7...7...7...7...8...8...9...9...10... 11... 11... 11... 11...12...12...13...16...18...20 1 1-1 1-2 1 1 km 24.5 m/s 10 50 m 1 1-3 μm 1-4 1-5 2 8 http://www.jma-net.go.jp/sat/himawari/obsimg/image_dust.html

More information

(Pantothenic acid, C 9 H 17 NO 5, MW: CH 3 OH HOCH 2 C CHCONHCH 2 CH 2 COOH CH 3 (Calcium pantothenate, C 18 H 32 CaN 2 O 10, MW: ) CH 3

(Pantothenic acid, C 9 H 17 NO 5, MW: CH 3 OH HOCH 2 C CHCONHCH 2 CH 2 COOH CH 3 (Calcium pantothenate, C 18 H 32 CaN 2 O 10, MW: ) CH 3 (Pantothenic acid, C 9 H 17 NO 5, MW: 219.24 CH 3 OH HOCH 2 C CHCONHCH 2 CH 2 COOH CH 3 (Calcium pantothenate, C 18 H 32 CaN 2 O 10, MW: 476.54) CH 3 CH 3 OH HOOC 2 HC 2 HCHNOCHC C OCH 2 Ca OCH 2 C CHCONHCH

More information

(Ⅱ)化学物質の環境リスク初期評価(13物質)の結果

(Ⅱ)化学物質の環境リスク初期評価(13物質)の結果 1 ( ) DBDPO CAS 1163-19-5 C 12 Br 10 O 959.2 2 1) 305 2) 3.0 1) 1- / (logp ow ) 1) 5.03 mmhg306 1) 1) 3) 4) 5) 1.010-4 6) mg/l25 3 7) OH 8) 4 9) 6 BOD 0% 14 100 mg/l 30 7) 10) BCF 5 < 42 60 mg/l 7) 50

More information

0724ジクロロフェノール.PDF

0724ジクロロフェノール.PDF [2,4-Dichlorophenol, CAS No. 120-83-2] 2,4-2,4-DCP 4- -1,3-2,4-DCP C 6 H 4 2 O 163.0 45 1) 210.0 1) 1. 383 d 60 25 = 1) 1) 16 Pa(25) 1) Log Pow = 3.06 2) BOD0 4 4.5 g/l(20) 1) 1) 3) 1) 1) HSDB, 2001; 2),

More information

untitled

untitled ORYZA POLYAMINE ORYZA POLYAMINE -P -PC -LC 1. Ver.1.0 MM ver. 1.0MM 1) Roseeuw D.I. et al., Epidermal keratinocytes actively maintain their intracellular polyamine levels. Cell Tissue Kinet. 16, 493-504

More information

1 I ( )

1 I ( ) 1 I. 3 1. 4 2. 6 3. 7 4. 8 4.1 8 4.2 ( ) 9 4.3 13 4.4 16 4.5 17 5. 19 5.1 20 5.2 25 5.3 33 6. 37 6.1 37 6.2 41 6.3 44 7. 46 7.1 46 7.2 47 II. 48 A 50 1 50 2 51 3 56 4 59 60 B 61 1 61 2 62 3 65 4 67 68

More information

平成26年度 化学物質分析法開発報告書

平成26年度 化学物質分析法開発報告書 N,N- N,N-Dimethylacetamide Acethyldimethylamine CAS 127-19-5 C 4 H 9 NO 87.12 ~ 87.14 87.68413 163-165 C 1) - 18.59 C 2) 1 mg/l 25 C 3) 3.3 hpa 2 C 4) log P ow -.77 2).9429 2/4 C 1) 3.1 4) 1.31E - 8 atm-m

More information

A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, Sc

A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, Sc A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, School of Medicine, Tokushima University, Tokushima Fetal

More information

1 2 D- D- 1206 D- D- -2003 120 /2004 D-FDA GRAS D D- 3 5 5 D- 75 10g/kg 14 40 20 D-101520 90 1520 20%101520 1520 D- 5(D- 2300-6700mg//) () 2024 615 D- 41220g/kg/ 1220g/kg/ 20g/kg/ 1220g/kg/ () 50 D- 10%

More information

46-2-最終版.pdf

46-2-最終版.pdf Jpn. J. Health Phys., 46 (2) 140 147 (2011) * 1 * 2 * 2 * 2 2010 10 22 2011 2 21 Development and Operational Results of a Real-time Remote Biological Information Monitoring Device for the Workers Wearing

More information

1 [2,4-Dichlorophenol, CAS No. 120-83-2] 2,4-2,4-DCP 4- -1,3-2,4-DCP C 6 H 4 Cl 2 O 163.0 OH Cl 45 1) 210.0 1) d 25 = 1.383 Cl 60 1) 16 Pa (25) 1) Log Pow = 3.06 1) BOD0 4 2) 4.5 g/l (20) 1) 1) 13 1) 3)

More information

L Aeq,24h db NITTS NIPTS 2 1 NITTS NIPTS WECPNL WECPNL db db 70% 30%

L Aeq,24h db NITTS NIPTS 2 1 NITTS NIPTS WECPNL WECPNL db db 70% 30% 9 9.1 NIPTS noise induced permanent threshold shift NITTS noise induced temporary threshold shift Tsan Ju Chen et al. 1992 112 5 dip 2 khz 25 db 65.2% 55.0% 41.7% 32.4% 0.0%5 Tsan Ju Chen et al. 1993 A

More information

水銀分析マニュアル

水銀分析マニュアル 16 3 2003 2 22 UNEP (Global Mercury Assessment) 2002 1 2 1 4 2 5 2 1 2 1 1 2 1 2 2 1 3 2 1 4 2 1 5 2 2 2 2 1 2 2 2 2 2 3 2 2 4 3 10 3 1 3 1 1 3 1 2 3 1 3 3 1 4 4 28 4 1 ECD 4 1 1 4 1 2 4 1 3 4 1 4 4 1

More information

<95DB8C9288E397C389C88A E696E6462>

<95DB8C9288E397C389C88A E696E6462> 2011 Vol.60 No.2 p.138 147 Performance of the Japanese long-term care benefit: An International comparison based on OECD health data Mie MORIKAWA[1] Takako TSUTSUI[2] [1]National Institute of Public Health,

More information

untitled

untitled 1% 1 mg 1 mg 2 CTD 6 Section 2.6.1 Introduction 2.6.1 H 1 descarboethoxyloratadinesch 34117 7.9 SCH 34117 2.6.1-1 O OC 2 H 5 Cl N N JAN Loratadine (JANINN) ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]

More information

資料7

資料7 SNUR TSCA EPA TSCA SNUR 600 SNUR SNUR SNUR EPA SNUR SNUR SNUR SNUR - 1 - Tris(2,3-dibromopropyl)phosphate; 126-72-7; SNUR 1,2,4,5-Tetrachlorobenzene; 95-94-3; SNUR 10,000 Benzenediazonium, 4-(dimethylamino)-,

More information

スライド タイトルなし

スライド タイトルなし 2003.11.25 JEMS/BMS 2 N H C C C NH 2 Furylfuramide (AF-2) Dibenzo[a, l ]pyrene ( DBP) PAH Mutant Frequencies of lacz and cii gene Induced by DBP and AF2 600 500 400 cii lacz cii lacz 300 200 100 0 Liver

More information

NL6

NL6 Aug. 2002 ISSN 1346-6992 1234567890123456789012345678901212345678901234567890123456789012123456789012345678901234567890121234 1234567890123456789012345678901212345678901234567890123456789012123456789012345678901234567890121234

More information

ナノ材料の有害性評価

ナノ材料の有害性評価 CRM CRM 181 TG424 TG42419971995TG407 PBPK PBPK DNA DNA PBPK C C art vein Ramsey & Andersen (1984) ( Qalv Cinh Qt Cvein ) ( Qt Qalv PN ) = + + { ( )} Qi Ci = i Pi ( C ) art Ci dai dt = Qi Qt Pi ( C ) art

More information

% 1% SEM-EDX - X Si Ca SEM-EDX SIMS ppm % M M T 100 % 100 % Ba 1 % 91 % 9 % 9 % 1 % 87 % 13 % 13 % 1 % 64 % 36 % 36 % 1 % 34 46

% 1% SEM-EDX - X Si Ca SEM-EDX SIMS ppm % M M T 100 % 100 % Ba 1 % 91 % 9 % 9 % 1 % 87 % 13 % 13 % 1 % 64 % 36 % 36 % 1 % 34 46 Review on Hair Analysis in the Wakayama Arsenic Case Jun KAWAI Department of Materials Science and Engineering, Kyoto University Sakyo-ku, Kyoto 606-8501, Japan Received 6 December 2014, Revised 29 December

More information

特論2

特論2 Bull. Natl. Inst. Health Sci., 124 Special report Hazardous Food-Borne Fungi, and the Present and Future Approaches to the Mycotoxin Regulations in Japan CladosporiumPecinilliumAspergillus 17 1,545 1,065

More information

参考資料5 農薬評価書 メタアルデヒド(食品安全委員会資料)

参考資料5 農薬評価書 メタアルデヒド(食品安全委員会資料) 1 3 3 4 5. 6 1. 6 2. 6 3. 6 4. 6 5. 6 6. 6 7. 6. 7 1. 7 2. 8 (1) 8 (2) 9 (3) 9 (4) 10 (5) 10 3. 11 (1) 11 (2) 11 (3) 11 (4) 12 4. 12 (1) 12 (2) 12 (3) 13 5. 13 6. 13 7. 14 8. 15 9. 16 10. 16 (1) 90 16-1

More information

1 ( 2)

1 ( 2) 2016 1 24 1. 10km 2. 1 50g 1 3. 1 4. 1mSv 5. 2 (0 ) 1 1 (http://www.itarda.or.jp/materials/statistical.php) (http://www.airia.or.jp/number/) 1 1 km 0.1691 1 1) 2) () ( km) (/ km) 2008 725 3847 0.1884 2009

More information

PAH ; XAD-2 ( XAD-2) PAH - LH-20 (HPLC) (SE-54 SE-52) ; -C18 HPLC PAH 1.3 PAH PAH PAH ( ) ( ) (, ) ( ) PAH : - bitumen ; - ; - ; - ; - ; - environment

PAH ; XAD-2 ( XAD-2) PAH - LH-20 (HPLC) (SE-54 SE-52) ; -C18 HPLC PAH 1.3 PAH PAH PAH ( ) ( ) (, ) ( ) PAH : - bitumen ; - ; - ; - ; - ; - environment No.202 Environmental Health Criteria No.202 (PAH) Selected Non-heterocyclic Polycyclic Aromatic Hydrocarbons ( 883 1998 ) 1. 1.1 (PAH) PAH PAH PAH 33 (31 PAH 2 ) ( 1) 8 10 PAH PAH 10-15 ; 1.2 ' ' 2 PAH

More information

O16200

O16200 1 0.9. Fe(3+) 161821) 21) 57) 0.11. 24-72 1 8001000ppm 18), 24) 18) (1) : ; 1) 24) (2) : ; 1 1618) ; 24-72 ; 8001000ppm30 (3) : ( ) ; ; (4) : 12 (5) : (7) * : 1 * : ( ) 1 ; 2 ; ; 23) *: *: 0.12. * 11618)

More information

HydroxypropylcelluloseCellulose 2-hydroxypropyl ether CH 2 OR R=H H O O H CH H 3 OR H CH 2 CH O m H OR m1 n 30,000n 100 1,000,000n 2,500 13) 1 14 C 14

HydroxypropylcelluloseCellulose 2-hydroxypropyl ether CH 2 OR R=H H O O H CH H 3 OR H CH 2 CH O m H OR m1 n 30,000n 100 1,000,000n 2,500 13) 1 14 C 14 HPC 1), 2), 3) HPC 4) 5) 6), 7), 8) GMPGood Manufacturing Practice EU 9) 10), 11) GMP 9) FAO/WHO JECFA 1989 35 7 HPC ADI not specified 12) 14 7 JECFA EU 46 HPC 16 8 16 EU - 1 - HydroxypropylcelluloseCellulose

More information

8 8.1 Lieberman; db Kisilevsky; 1989 Hartikainen; db 90 db Ando & Hattori; 1973 Suzuki & Kabuto; ,000 2,500g 13 Lagers

8 8.1 Lieberman; db Kisilevsky; 1989 Hartikainen; db 90 db Ando & Hattori; 1973 Suzuki & Kabuto; ,000 2,500g 13 Lagers 8 8.1 Lieberman; 1975 100 105 db Kisilevsky; 1989 Hartikainen; 1994 78 db 90 db Ando & Hattori; 1973 Suzuki & Kabuto; 1978 713 40,000 2,500g 13 Lagerstrom et al.; 1991 Rantakallio; 1985, McDermott et al.;

More information

2001 2003 2005 2006 2007 2008

2001 2003 2005 2006 2007 2008 2001 2003 2005 2006 2007 2008 60 etc. http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8% AAN 65

More information

繁殖性に及ぼす影響

繁殖性に及ぼす影響 5. 2 1. (DEP) 1) DEP 2) 3) 4) DEP 0 600 3000 15000 ppm(0 43 210 1083 mg/kg/day 0 54 261 1336 mg/kg/day ) 24 Crj:CD(SD) IGS 2 DEP 15000 ppm F0 0-21 F1 F0 F1 DEP F1 F1 15000 ppm 15000 ppm F0 F1 F0 F0 P-450

More information

15K00827 研究成果報告書

15K00827 研究成果報告書 (TG) TG sterol regulatory element- binding protein (SREBP)-1c (Diabetes 53:560-569, 2004) SREBP-1c (1) SREBP-1c SREBP-1c liver X receptor (LXR)LXR O-Glc NAc (O-linked -N-acetyl glucosamine) (J Biol Chem

More information

20mg CTD 2.4 2.4 2.4... 5 2.4.1... 5 2.4.2... 7 2.4.3... 10 2.4.4... 13 2.4.5... 18 2.4.6... 20 3 2.4 2.4 2.4.1 JNS002 ( HSPC) N-(Carbonyl-methoxypolyethylene glycol 2000)-1,2- distearoyl-sn-glycero-3-phosphoethanolamine

More information

平成13年度内分泌攪乱化学物質のヒトへの健康影響調査研究報告書

平成13年度内分泌攪乱化学物質のヒトへの健康影響調査研究報告書 . 1,3 4 5. 1 2 NB-1 MCF7 MEIC 1-3 4-6 NB-1 JCRB Japan Cancer Research Bank MCF ATCCAmerican Type Culture Collection 2 19994 212 11 PVDF.22µm 8 2 11 4 4 3 5 1 4 cellsml -1 96 4,6 NB-1 48 MCF7 24 4 5 48

More information

No.7, (2006) A Survey of Legislation Regarding Environmental Information in Europe and Japan IWATA Motokazu Nihon University, Graduate School of

No.7, (2006) A Survey of Legislation Regarding Environmental Information in Europe and Japan IWATA Motokazu Nihon University, Graduate School of No.7, 35-44 (2006) A Survey of Legislation Regarding Environmental Information in Europe and Japan IWATA Motokazu Nihon University, Graduate School of Social and Cultural Studies As Principle 10 of the

More information

untitled

untitled 1 2 3 http://www.info.pmda.go.jp/ 4 5 6 7 8 9 10 11 (Quincke s edema) 12 13 梗 疼 () 14 15 J Allergy Clin Immunol 115;S483-S523, 2005 16 17 IgE IgE IgE 18 19 20 21 腿 22 Hydrocortisone 100 200 mg 5 mg/kg

More information

研究成果報告書

研究成果報告書 系 レニン 1. Ito D, Ito O, Mori N, Suda C, Hao K, Cao P, Muroya Y, Takashima K, Shimokawa H, Kohzuki M. Exercise training upregulates nitric oxide synthases in the kidney of rats with chronic heart failure.

More information

_念3)医療2009_夏.indd

_念3)医療2009_夏.indd Evaluation of the Social Benefits of the Regional Medical System Based on Land Price Information -A Hedonic Valuation of the Sense of Relief Provided by Health Care Facilities- Takuma Sugahara Ph.D. Abstract

More information

NEWS LETTER No.10 (Page 1)

NEWS LETTER No.10 (Page 1) Who When Where What Why How Who When Where What Why How U.S. Department of Agriculture / U.S. Department of Health and Human Services Guide Line PEOPLE'S REPUBLIC OF CHINA GUIDE LINE NORWAY WHO WHEN WHERE

More information

身のまわりの電磁界について

身のまわりの電磁界について 28 4 1 3 2 3 4 4 4 5 5 6 6 7 7 8 9 8 8 9 2 1 3 2 0Hz 0Hz 300Hz 300Hz 10MHz 1000km 30m 1000km 10MHz 300GHz 1mm 30m 3 IH TV 4 4 5 5 WHO 0-300GHz MRI 6 WHO WHO 6 7 7 WHO ICNIRP ICNIRP EUEU 150 8 ICNIRP

More information

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Journal Physiology, American Journal of Physiology, Journal of Physiology, Journal of Autonomic Nervous System, American Journal of Physiology,

More information

VOL. 21 NO. 2 CHEMOTHERAPY 395

VOL. 21 NO. 2 CHEMOTHERAPY 395 394 CHEMOTHERAPY MAR. 1973 VOL. 21 NO. 2 CHEMOTHERAPY 395 396 CHEMOTHERAPY MAR. 1973 VOL. 21 NO. 2 CHEMOTHERAPY 397 398 CHEMOTHERAPY MAR. 1973 VOL. 2 1 NO. 2 CHEMOTHERAPY 399 400 CHEMOTHERAPY MAR. 1973

More information

Ⅰ. 緒言 Suzuki, et al., Ⅱ. 研究方法 1. 対象および方法 1 6 表 1 1, 調査票の内容 図

Ⅰ. 緒言 Suzuki, et al., Ⅱ. 研究方法 1. 対象および方法 1 6 表 1 1, 調査票の内容 図 The Journal of the Japan Academy of Nursing Administration and Policies Vol 12, No 1, pp 515, 2008 原著 病棟勤務看護師の勤務状況とエラー ニアミスのリスク要因 Relationship between Risk Factors Related Medical Errors and Working Conditions

More information

1. PVC PVC DEHP DEHP PVC PVC PVC PVC , PVC , ,596 PVC ,472 16% PVC

1. PVC PVC DEHP DEHP PVC PVC PVC PVC , PVC , ,596 PVC ,472 16% PVC (2- ) 2003 5 1. PVC PVC DEHP DEHP 2. 2.1 PVC PVC PVC 1930 1941 PVC 1943 37,000 1944 116 200500 PVC 1950 1,493 2000 268 2,596 PVC 2000 1,472 16% PVC 1948 190 2000 36 470 8% 80% DEHP 60% 50% DEHP PVC % 2.2

More information

(1) (2) (1) (2) (1) Seg (2) Seg (3) Seg (4) Seg (1) (2) (3) ( ) (1) (PCA)...12

(1) (2) (1) (2) (1) Seg (2) Seg (3) Seg (4) Seg (1) (2) (3) ( ) (1) (PCA)...12 (1)...109 (2)...110 (1) 28...111 (2) 28...113 (1) Seg...115 (2) Seg...117 (3) Seg...119 (4) Seg...120 (1)...122 (2)...122 (3) ( )...126 (1) (PCA)...127 (2) Draize...128 (1) Ames...129 2 in vitro...132

More information

A5 PDF.pwd

A5 PDF.pwd Global Reporting Initiative GRI 2013 International Integrated Reporting Council: IIRC IIRC 2013 European Union: EU European Parliament and the Council of the European Union 2014 Public Interest EntitiesPIE

More information

平成14年度 本態性多種化学物質過敏状態の調査研究 研究報告書

平成14年度 本態性多種化学物質過敏状態の調査研究 研究報告書 226 227 µ 228 Ω 229 230 0 ppb 2000ppb DG subthreshold (µa) 91 ± 59 86 ± 68 max stim. (µa) 755 ± 287 n=37 678 ± 300 max PS (mv) 8.7 ± 3.9 7.7 ± 4.3 n=61 CA1 subthreshold (µa) 36 ± 26 32 ± 13 max stim. (µa)

More information

untitled

untitled EU REACHEuPRoHS 1 2 2.1 REACH 2.1.1 REACH 2.1.2 2.2 EuP 2.3 RoHS 2.4 2.5 EU 2.6 1. (EU) REACH 1 (6 1 ) 2. 2.1 REACH 2.2 EuP 2 2005 4 2.3 RoHS 3 2.4 2007 2.5 2.6 1 (REACH:Registration,Evaluation,Authorization,and

More information

資料3 諸外国における位置づけ

資料3 諸外国における位置づけ 1 1. ( 1) ) 2) 3) 4) 5) 6) 7) 8) 9) 10) 11) 12) 13) 14) 15) 16) ( 1) ) 2) 3) 4) 5) 6) 7)28 8)Ames 9) 10) 11) ( 1) ) 2) 3) 4) ( 1) ) 2) 3) 4) 2 TSCA (a) FIFRA (b) (c) FFDCA (d) FFDCA (e) FFDCA (f) (g) PMN

More information

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案) VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.

More information

グルタルアルデヒドの測定手法検討結果

グルタルアルデヒドの測定手法検討結果 資料 1-5 グルタルアルデヒドの測定手法検討結果 1. はじめに 2. 予備試験 2-1. 捕集方法の決定 2-2. 検出方法の選択 (HPLC 法 ) 2-3-1. 前処理 2-3-2.HPLC 分析条件 3. 本試験 3-1. 捕集及び分析条件 3-2. 添加回収率 3-3. 捕集後のサンプラーの保存安定性 3-4. 検量線 ( 直線性 ) 3-5. 検出下限及び定量下限 3-6. 本分析方法の作業環境中

More information

200mg 2005 3 876179 2002 3 3 200mg VFEND for Intravenous Use (1) (2) [4.1 ] (3) [4.2 ] (1) [1] (2) (3) [1] 3

More information

: / FDA HBsAg HIV 1/2 HCV : QMS : 3.5% IgM () 1.0% H317 - H334 - : : :: : QMS Everolimus : 6.4% (II) H400 - H % SDS QMS EDTA (K 3 ) EDTA (K 2 )

: / FDA HBsAg HIV 1/2 HCV : QMS : 3.5% IgM () 1.0% H317 - H334 - : : :: : QMS Everolimus : 6.4% (II) H400 - H % SDS QMS EDTA (K 3 ) EDTA (K 2 ) QMS (EVER) 0373852 (QMS) QMS QMS X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X

More information

Juntendo Medical Journal

Juntendo Medical Journal * Department of Health Science Health Sociology Section, Juntendo University School of Health and Sports Science, Chiba, Japan (WHO: Ottawa Charter for Health promotion, 1986.) (WHO: Bangkok Charter

More information

1) Dalton, A. J. et al. : J. Nat. Cancer Inst., 11 : 439, 1950. 2) Fawcett, D. W.: J. Nat. Cancer Inst., 15 :1475, 1955. 3) Oberling, C. et Rouiller, C.: Ann. d'anat. path., 1: 401, 1956. 4) Palade, G.

More information

2009年133巻3号3月号.indb

2009年133巻3号3月号.indb Folia Pharmacol. Jpn.133 1 2 Chiroscience UCB S RR-..% AA C IC C/A A/ A R- II/ III II/III Chiroscience UCB S 1 - E-mail: koji_taya@maruishi-pharm.co.jp Author: Koji Taya, Satoshi Shimizu Title: Levobupivacaine

More information

Public Relations KOSA December 2015 2

Public Relations KOSA December 2015 2 Public Relations KOSA December 2015 2 Public Relations KOSA December 2015 3 Public Relations KOSA December 2015 4 Public Relations KOSA December 2015 5 Public Relations KOSA December 2015 6 Public Relations

More information

Public Relations KOSA August 2015 2

Public Relations KOSA August 2015 2 Public Relations KOSA August 2015 2 Public Relations KOSA August 2015 3 Public Relations KOSA August 2015 4 5 Public Relations KOSA August 2015 Public Relations KOSA August 2015 6 Public Relations KOSA

More information

国際比較からみた介護システムの役割分担

国際比較からみた介護システムの役割分担 * OECDLong-term Care for Older People E-mail: lfy@hotmail.co.jp Long-term care Long-term care for older people OECDLTC GDP. OECD WHOHealth life expectancy : HALE GDP Martins et al OECD OECD OECD Residential

More information

Ⅰ. Statistics Concerning Health Birthweight (1) Birthweight by year (2) Mean birthweight by prefecture, 2007-1997 (3) Percentage of births under 2,500g by prefecture, 2007-1997 Sex Ratio (4) Sex ratio

More information

化学物質の内分泌かく乱作用に関する環境省の今後の対応方針について

化学物質の内分泌かく乱作用に関する環境省の今後の対応方針について ExTEND2005 2005 3 ExTEND2005 Enhanced Tack on Endocrine Disruption 10 (1998 )5 - SPEED'98-12 (2000 )11 2000 11 ( SPEED'98 ) 14 (2002 )8 (WHO)/ (ILO)/ (UNEP) Global Assessment of the State-of-the-Science

More information

精神障害者

精神障害者 13 ACT 156-8585 2-1-8 TEL03-3304-5701 14 10 30 ACTassertive community treatment 1 ACT ACT ACT ACT Fidelity ScaleACT ACT ACT ACT ACT Fidelity 2000, 2001; 1994 Tessler & Gamache 2000 14 1 2002 1986 1994

More information

2007050781......_.L.O...z.W

2007050781......_.L.O...z.W a s d f g a s d f g h j k l 0 in vitro in vivo in vitro in vivo in vivo in vivo in vitro Metabolism Metabolism Endocr Endocr Endocrinol Ann NYA cad Sci J clin Endocr Metab

More information